X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
Details:
HRA is one of the fastest growing over-the-counter ("OTC") companies globally, with three category-leading self-care brands in blister care (Compeed®), women's health (ellaOne®) and scar care (Mederma®).
Lead Product(s): Ulipristal Acetate
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: ellaOne
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Perrigo Company plc
Deal Size: Undisclosed Upfront Cash: $2,100.0 million
Deal Type: Acquisition September 08, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
